Detailed View
IMMX - Immix Biopharma, Inc.
Latest filing: 2025-09-30 | Reporting: gaap
Market Cap
570,326,784
Adj EBIT (TTM)
-24,050,259
Enterprise Value
554,379,476
Last Price
10.77
Earnings Yield
-4.34%
Return on Capital
-260.57%
Capital
9,230,023
1Y Price Chart
Last Price: $10.77
1Y Change: 552.73%
As of 2026-03-16 | 1Y Change: 552.73%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2025-09-30 | 10-Q | 2025 | 0 | -7,662,509 |
| 2025-06-30 | 10-Q | 2025 | 0 | -6,717,705 |
| 2025-03-31 | 10-Q | 2025 | 0 | -4,682,925 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 0 | -4,987,120 |
| 2024-09-30 | 10-Q | 2024 | 0 | -7,394,931 |
| 2024-06-30 | 10-Q | 2024 | 0 | -4,702,496 |
| 2024-03-31 | 10-Q | 2024 | 0 | -5,590,133 |
| 2023-12-31 | 10-K (Q4 derived) | 2023 | 0 | -5,375,852 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.